CA15-3 is upregulated and aberrantly glycosylated in breast and other carcinomas [18].The CA15-3, derived from a large transmembrane protein Mucin 1 with molecular weight ranging from 500 to 1000 kDa, contains multiple O- and N-linked glycosylation sites. The gene discussed is MUC1; the disease is carcinoma.